Moreover, in a study that explored whether CSF biomarkers of neuroinflammation independently predict and provide an indication of the pathology and neuronal damage associated with Alzheimer’s disease, there were elevated levels of IP-10 in patients with the disease compared to controls with normal cognitive function. This evidence concerns the gene CXCL10 and Alzheimer disease.